Pfizer Won’t Split-up, Shareholders See More Deals

Investors and shareholders of Pfizer Inc are expecting more deals that could bolster its roster of new medicines after the company, which was considering splitting itself for more than two years, said on Monday it would not do so. Cash flow would not be boosted nor would the position the businesses be bettered competitively by…